50.62

0.12% 0.155

Hims Hers Health Inc (HIMS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HIMS Giù? Forum Previsione

Precedente Chiudi:

$50.46

Aprire:

$51

Volume 24 ore:

4.83M

Relative Volume:

0.11

Capitalizzazione di mercato:

$10.87B

Reddito:

$1.78B

Utile/perdita netta:

$164.40M

Rapporto P/E:

73.36

EPS:

0.69

Flusso di cassa netto:

$236.51M

1 W Prestazione:

-1.41%

1M Prestazione:

-15.49%

6M Prestazione:

+80.82%

1 anno Prestazione:

+118.61%

Intervallo 1D:

$49.61

$51.00

Intervallo di 1 settimana:

$47.36

$53.24

Portata 52W:

$13.47

$72.98

Hims Hers Health Inc Stock (HIMS) Company Profile

Nome

Hims Hers Health Inc

Settore

Consumer Defensive (251)

Industria

Household & Personal Products (32)

Telefono

415-851-0195

Indirizzo

2269 CHESTNUT ST, SAN FRANCISCO

Dipendente

1,637

Cinguettio

Prossima data di guadagno

2025-02-24

Ultimi documenti SEC

HIMS's Discussions on Twitter

Confronta HIMS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HIMS Hims Hers Health Inc	50.43	10.96B	1.78B	164.40M	236.51M	0.69
PG Procter Gamble Co	153.07	370.18B	83.93B	15.50B	15.03B	6.30
UL Unilever Plc Adr	60.09	149.34B	65.10B	6.16B	0	2.4569
CL Colgate Palmolive Co	87.63	74.67B	19.95B	2.90B	3.47B	3.54
KMB Kimberly Clark Corp	126.94	43.60B	19.75B	2.47B	2.39B	7.34
KVUE Kenvue Inc	21.38	39.74B	15.30B	1.06B	1.45B	0.55

Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-06-23	Downgrade	Needham	Buy → Hold
2025-06-04	Reiterato	Needham	Buy
2025-04-29	Downgrade	TD Cowen	Buy → Hold
2025-02-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2025-01-10	Downgrade	Citigroup	Neutral → Sell
2025-01-07	Iniziato	BTIG Research	Buy
2024-12-17	Iniziato	Morgan Stanley	Overweight
2024-11-14	Downgrade	BofA Securities	Buy → Underperform
2024-08-22	Iniziato	Needham	Buy
2024-08-09	Downgrade	Imperial Capital	Outperform → In-line
2024-05-22	Downgrade	Citigroup	Buy → Neutral
2024-04-16	Downgrade	Jefferies	Buy → Hold
2024-04-10	Iniziato	Canaccord Genuity	Buy
2024-02-28	Aggiornamento	Imperial Capital	In-line → Outperform
2024-02-26	Iniziato	Leerink Partners	Market Perform
2023-12-07	Iniziato	Imperial Capital	In-line
2023-07-28	Iniziato	TD Cowen	Outperform
2023-04-11	Iniziato	Robert W. Baird	Neutral
2023-02-09	Aggiornamento	Jefferies	Hold → Buy
2022-11-08	Aggiornamento	BofA Securities	Neutral → Buy
2022-11-08	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2022-10-17	Downgrade	Piper Sandler	Overweight → Neutral
2022-09-07	Iniziato	Truist	Hold
2022-07-15	Iniziato	SVB Leerink	Underperform
2022-04-14	Iniziato	Guggenheim	Buy
2022-04-01	Ripresa	Credit Suisse	Outperform
2022-03-10	Iniziato	Deutsche Bank	Hold
2021-12-02	Iniziato	Jefferies	Hold
2021-11-11	Aggiornamento	Piper Sandler	Neutral → Overweight
2021-07-06	Iniziato	BofA Securities	Neutral
2021-05-20	Aggiornamento	Credit Suisse	Neutral → Outperform
2021-04-21	Iniziato	Truist	Hold
2021-03-09	Iniziato	Credit Suisse	Neutral
2021-03-02	Aggiornamento	Citigroup	Neutral → Buy
2021-02-17	Iniziato	Citigroup	Neutral
2021-02-12	Iniziato	Piper Sandler	Neutral
2021-02-08	Iniziato	Tigress Financial	Buy

Mostra tutto

Hims Hers Health Inc Borsa (HIMS) Ultime notizie

08:45 AM

Hims & Hers Health Is Looking to Cash In on This Novo Nordisk Blunder - Yahoo Finance

08:45 AM

07:56 AM

Hims & Hers faces lawsuits after Novo deal exit (HIMS:NYSE) - Seeking Alpha

07:56 AM

07:52 AM

Securities Lawsuit Alert: Hims & Hers Health, Inc. (HIMS) InvestorsContact Levi & Korsinsky Before August 25, 2025 - ACCESS Newswire

07:52 AM

Jul 15, 2025

Why Hims & Hers Management Might Be Its Most Valuable Asset - Seeking Alpha

Jul 15, 2025

HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA - GlobeNewswire

Jul 15, 2025

Hims & Hers hit with investor lawsuits after Novo ends Wegovy partnership - Reuters

Jul 15, 2025